Skip to content

Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea

Effects of Renal Denervation on Blood Pressure and Clinical Course of Obstructive Sleep Apnea in Patients With Resistant Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01366625
Enrollment
60
Registered
2011-06-06
Start date
2011-07-31
Completion date
2016-11-28
Last updated
2017-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Obstructive Sleep Apnea

Keywords

hypertension, resistant, obstructive sleep apnea, renal denervation, continuous positive airway pressure therapy

Brief summary

The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of resistant hypertension coexisting with obstructive sleep apnea.

Interventions

DEVICERenal denervation with a catheter-based procedure (Symplicity® Catheter System)

Disruption of the renal nerves with a catheter-based procedure.

Sponsors

National Institute of Cardiology, Warsaw, Poland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* \>= 18 and =\< 70 years of age. * systolic blood pressure \>=140mmHg (office); * on 3 or more antihypertensive medications (including diuretic) * mean daytime systolic ABPM \>= 135 mmHg * obstructive sleep apnea (AHI \>=15 event/hour, indications for CPAP treatment)

Exclusion criteria

* renal artery abnormalities * eGFR \< 60mL/min * previous TIA, stroke, heart failure * Type 1 diabetes * ICD or pacemaker * others

Design outcomes

Primary

MeasureTime frame
Blood Pressure Reduction3 months

Secondary

MeasureTime frame
Responses to renal denervation (e.g., blood pressure reduction, sleep apnea course, metabolic assessment, cardiac changes)Through 1 year

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026